Laidlaw Capital Markets is pleased to have served as Financial Advisor to Arcturus Therapeutics on its $173,000,000 financing alongside Citigroup, Guggenheim Securities, and Barclays. Laidlaw has helped Arcturus in its efforts in 2020 raise approximately $250,000,000.
Ann Marie Sastry, founder and CEO of Amesite, joins “Squawk Box” to discuss how the Covid-19 pandemic is changing remote learnings for students and workers looking to continue their education.”
Laidlaw Venture Partners, the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Jeff Conroy and George Serafin to its Board of Advisors. As industry leaders in Business Development and Regulatory/Compliance, both Conroy and Serafin bring years of strategic experience to Laidlaw Venture Partners and will be instrumental in the development and evolution of our innovative companies.
Laidlaw is pleased to have Co-Managed a $50,000,000 deal for Soleno Therapeutics (SLNO) with Guggenheim Partners.
Laidlaw Capital Markets is pleased to announce yesterday’s pricing of a $5,000,000 Follow-On Offering for Hoth Therapeutics (HOTH). Laidlaw proudly served as the Sole Book Runner on the transaction.
Laidlaw Venture Partners client Biosig Technologies (BSGM) through its newly formed subsidiary ViralClear, closes $10,800,000 financing. Laidlaw is proud to have acted as am Introducing Broker on this financing.
Laidlaw Capital Markets is pleased to have acted as Co-Lead Manager on Delcath Systems’ (DCTH) $22,000,000 financing and uplisting to NASDAQ. Laidlaw proudly served as the Sole Book Runner on the transaction.
Laidlaw Capital Markets is pleased to announce today’s pricing of a $70,000,000 Follow-On Offering for Arcturus Therapeutics (ARCT) around its Covid-19 vaccine and platform for other diseases. Laidlaw proudly served as Financial Advisor alongside Guggenheim, who was Sole-Book Runner on the transaction.
Welcome to “A Brighter Future”, our new Podcast Series. Listen to our fourth session of the Laidlaw Five, our ongoing Podcasts of A Brighter Future.
A must listen for every investor.
Welcome to “A Brighter Future”, our new Podcast Series. Listen to our third session of the Laidlaw Five, our ongoing Podcasts of A Brighter Future.
A must listen for every investor.
This link is provided as a service to you, and will take you to a third party site not affiliated with this site. We are not responsible for the content and do not guarantee the accuracy of any information or material contained therein Laidlaw & Company provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained by Laidlaw & Company, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.
Click the link above to continue or CANCEL
COVID-19 Letter